Home LiteratureArticle Details
PMID: 15381726 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.

The Journal of experimental medicine ·Vol. 200 ·No. 6 ·2004-09-20 ·Pages 701-12

Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, Johnston MN, Cohen D, Robbins GK, Pae E, Alter G, Wurcel A, Stone D, Rosenberg ES, Walker BD, Altfeld M

Abstract

Virus-specific CD8(+) T cells are associated with declining viremia in acute human immunodeficiency virus (HIV)1 infection, but do not correlate with control of viremia in chronic infection, suggesting a progressive functional defect not measured by interferon gamma assays presently used. Here, we demonstrate that HIV-1-specific CD8(+) T cells proliferate rapidly upon encounter with cognate antigen in acute infection, but lose this capacity with ongoing viral replication. This functional defect can be induced in vitro by depletion of CD4(+) T cells or addition of interleukin 2-neutralizing antibodies, and can be corrected in chronic infection in vitro by addition of autologous CD4(+) T cells isolated during acute infection and in vivo by vaccine-mediated induction of HIV-1-specific CD4(+) T helper cell responses. These data demonstrate a loss of HIV-1-specific CD8(+) T cell function that not only correlates with progressive infection, but also can be restored in chronic infection by augmentation of HIV-1-specific T helper cell function. This identification of a reversible defect in cell-mediated immunity in chronic HIV-1 infection has important implications for immunotherapeutic interventions.

MeSH Terms
AIDS Vaccines/immunology Acquired Immunodeficiency Syndrome/immunology Acute Disease Adult Amino Acid Sequence CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology Cells, Cultured Female HIV-1/immunology Humans Interferon-gamma/biosynthesis Interleukin-2/physiology Lymphocyte Activation Male Middle Aged Molecular Sequence Data
Chemicals
AIDS Vaccines Interleukin-2 Interferon-gamma
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Lichterfeld Mathias
Partners AIDS Research Center, Massachusetts General Hospital, 149 13th St., Boston, MA 02129, USA.
Kaufmann Daniel E
Yu Xu G
Mui Stanley K
Addo Marylyn M
Johnston Mary N
Cohen Daniel
Robbins Gregory K
Pae Eunice
Alter Galit
Wurcel Alysse
Stone David
Rosenberg Eric S
Walker Bruce D
Altfeld Marcus
References (30)
30 references, click to expand
  1. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection.
    J Immunol. 2003 Jul 1;171(1):477-88 PMID: 12817033
  2. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    J Virol. 2004 Jan;78(2):630-41 PMID: 14694094
  3. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.
    J Virol. 2003 Oct;77(20):10900-9 PMID: 14512540
  4. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.
    J Exp Med. 2003 Dec 15;198(12):1909-22 PMID: 14676302
  5. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.
    Blood. 2004 Feb 1;103(3):966-72 PMID: 12958069
  6. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
    J Acquir Immune Defic Syndr. 2004 May 1;36(1):576-87 PMID: 15097300
  7. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  8. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  9. HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity: results of a double-blind, adjuvant-controlled, dose-ranging trial.
    AIDS. 1994 Oct;8(10):1429-35 PMID: 7818813
  10. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  11. In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune).
    Clin Diagn Lab Immunol. 1998 May;5(3):308-12 PMID: 9605982
  12. Acute human immunodeficiency virus type 1 infection.
    N Engl J Med. 1998 Jul 2;339(1):33-9 PMID: 9647878
  13. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  14. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    J Virol. 2003 Jun;77(12):6867-78 PMID: 12768006
  15. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    J Infect Dis. 2003 Mar 1;187(5):748-57 PMID: 12599048
  16. HIV-specific immunity during structured antiviral drug treatment interruption.
    Vaccine. 2003 Mar 7;21(11-12):1066-71 PMID: 12559781
  17. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  18. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Nat Immunol. 2002 Nov;3(11):1061-8 PMID: 12368910
  19. Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.
    J Infect Dis. 2002 Jan 1;185(1):61-8 PMID: 11756982
  20. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    J Virol. 2001 Dec;75(24):11983-91 PMID: 11711588
  21. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  22. Vpr is preferentially targeted by CTL during HIV-1 infection.
    J Immunol. 2001 Sep 1;167(5):2743-52 PMID: 11509618
  23. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
    J Exp Med. 2001 Jan 15;193(2):169-80 PMID: 11148221
  24. Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogen.
    AIDS. 2000 Nov 10;14(16):2475-8 PMID: 11101057
  25. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Blood. 2000 Nov 1;96(9):3094-101 PMID: 11049989
  26. Immune control of HIV-1 after early treatment of acute infection.
    Nature. 2000 Sep 28;407(6803):523-6 PMID: 11029005
  27. HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant.
    J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):264-9 PMID: 10969351
  28. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
    J Clin Invest. 1999 Nov;104(10):1431-9 PMID: 10562305
  29. Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.
    J Virol. 2001 Nov;75(22):10843-55 PMID: 11602725
  30. Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization.
    AIDS. 2003 May 23;17(8):1121-6 PMID: 12819512
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2004-09-20
Pages
701-12
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2211961
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]